MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202641113478 A) filed by Anurag University on September 22, 2026, for A Lyophilized Mouth-Dissolving Tablet Composition Of Sumatriptan Succinate And Process Thereof For Migraine Management.
Inventors include Dr. Ravi Sheshala; Dr. Yusrida Darwis; and Dr. Nurzalina Khan.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: ABSTRACT The present invention relates to a lyophilized mouth-dissolving tablet composition (100) of sumatriptan succinate for migraine management. The composition comprises sumatriptan succinate as an active pharmaceutical ingredient, Eudragit EPO as a taste-masking polymer, at le...